Astronaut Kellie Gerardi has been taking TikTok followers on her IVF journey. She announced in a heartbreaking video that her ...

Researchers suggest drugs that prevent cholesterol from being converted to 24-OHC might therefore be an effective treatment for Parkinson's disease.

Bayer's subsidiary AskBio received approval from the U.S. drug regulator to accelerate the development of its investigational gene therapy to treat moderate-stage Parkinson's disease.

AbbVie's growth thrives on strong earnings, a robust immunology portfolio, and diversification. See why ABBV stock is a ...

A breakthrough study has uncovered a hidden player in Parkinson’s disease—24-OHC, a cholesterol metabolite that fuels the ...

Dr. Cheng's team continues to explore AI's potential in drug repurposing for neurodegenerative diseases. Their findings suggest that reducing cholesterol, glucose levels and blood pressure through ...

We rely on singers and musicians for an outlet. They take the stage, and we can follow along and forget all of our problems while getting lost in the music. But in 2025, a growing list of our favorite ...

Rock Valley College (RVC) hosted a meeting for caretakers and friends to learn how to better care for people who suffer from Parkinson's Disease.

The narrative is false that the COVID vaccine was rushed and not properly tested. It and other vaccines are safe and ...

Alumis Inc. will merge with a Southern California drug developer in a deal that extends the combined companies' cash into ...

Supernus Pharmaceuticals has won US approval for its wearable pump Onapgo (apomorphine hydrochloride) to treat symptoms of Parkinson’s disease. Supernus’ regulatory path for Onapgo has been marked by ...

AstraZeneca’s diabetes drug Bydureon (exenatide) has failed to slow the progression of Parkinson’s disease motor symptoms in a Phase III trial. The University College London (UCL) in the UK ...